Abdominal MR Imaging at 3.0T: Sequence Optimization and Implementation

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01007357

Enrollment

Registered

2009-11-04

Start date

2009-12-15

Completion date

2015-06-30

Last updated

2023-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diffuse and Focal Abnormalities of the Liver and Pancreas

Brief summary

This project will facilitate the optimization of body MR imaging at 3 Tesla.

Detailed description

This project is meant to improve the image quality of multiple sequences at 3.0T applied to the abdominal and pelvic regions.

Interventions

DEVICEBody MR imaging

Body MR imaging will be performed to optimize sequences

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

19 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* Subjects between ages of 19 and 65 * Healthy volunteer subjects should not have any history of disease or symptoms - based on clinical history * Subjects with an underlying disorder (diffuse and focal abnormalities of the liver and pancreas)

Exclusion criteria

* Inability to provide informed consent * A medical or contraindications that will prevent subjects from having a MRI * Subjects with severe renal dysfunction or patients on dialysis

Design outcomes

Primary

Measure	Time frame	Description
Optimizing body MR imaging sequences	2 years	Healthy volunteers will be used to obtain optimized body MR imaging sequences that will then be used to evaluate MR imaging sequences of subjects with underlying disorders.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026